Molecular biomarkers for vascular cognitive impairment and dementia:the current status and directions for the future

作     者：Satoshi Hosoki Perminder SSachdev Satoshi Hosoki;Perminder S.Sachdev

作者机构：Centre for Healthy Brain AgeingDiscipline of Psychiatry and Mental HealthSchool of Clinical MedicineFaculty of Medicine and HealthUniversity of New South WalesSydneyAustralia Department of NeurologyNational Cerebral and Cardiovascular CenterOsakaJapan 

出 版 物：《Neural Regeneration Research》 (中国神经再生研究（英文版）)

年 卷 期：2024年第19卷第12期

页      面：2579-2580页

核心收录：

学科分类：0710[理学-生物学] 1002[医学-临床医学] 1001[医学-基础医学(可授医学、理学学位)] 100203[医学-老年医学] 10[医学] 

基　　金：supported by the Japan Society for the Promotion of Science Overseas Research Fellow the fellowship of Astellas Foundation for Research on Metabolic Disorders and the Japanese Society of Neurology grants for overseas study“Young Researcher Overseas Training Program” (SH)and NHMRC CRE grant 2006765 (to PSS) 

主　　题：prevention diagnosis impairment 

摘      要：Dementia is a syndrome with various underlying pathologies acting independently or in concert to cause cognitive *** development of disease-specific treatments and targeted prevention strategies requires precise clinical sub-typing via etiology and pathophysiological ***,recent research advances in biomarkers,especially for Alzheimer s disease(AD)diagnosis,have improved diagnostic precision for dementia.